CMS is drafting a rule to streamline the prior authorization of certain drugs by Medicare Advantage and Qualified Health Plans and expects to publish the proposal in November, HHS reveals in its newly released regulatory agenda. News of the upcoming regulatory proposal comes after CMS hinted its work on prior authorization was not done after finalizing a major rule that excluded drugs earlier this year. CMS Administrator Chiquita Brooks-LaSure told hospitals during a conference in April that the agency was...